Form EFFECT iTeos Therapeutics, Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 4, 2025 |
| Accession Number: | 0001140361-25-033424 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Operators and Fulfil Launch the Operators Portal: 4.7 Million Words of Real Ecommerce Strategy, Now AI-Searchable in Seconds
- Moon River Moly Ltd. Announces Engagement of Concentrator Support Ltd. as Project Manager for the Davidson Molybdenum-Copper-Tungsten Deposit and Grant of Stock Options
- Takeda’s Zasocitinib Demonstrates Consistent, High Rates of Skin Clearance Across the Body, Including Hard-to-Treat and High-Impact Sites, in Phase 3 Psoriasis Studies
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
